Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
about
Accessing biological actions of Ganoderma secondary metabolites by in silico profilingAnti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.Networks of Host Factors that Interact with NS1 Protein of Influenza A VirusA High Throughput Assay for Screening Host Restriction Factors and Antivirals Targeting Influenza A Virus.Iminosugars: Promising therapeutics for influenza infection.Animal models for influenza viruses: implications for universal vaccine developmentA virtual screening approach for identifying plants with anti H5N1 neuraminidase activity.3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus.Evaluation of Unbiased Next-Generation Sequencing of RNA (RNA-seq) as a Diagnostic Method in Influenza Virus-Positive Respiratory Samples.Emergence of Hemagglutinin Mutations During the Course of Influenza Infection.Influenza virus-host interactomes as a basis for antiviral drug development.Disentangling the Frames, the State of Research on the Alphavirus 6K and TF Proteins.Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.Nuclear translocation of HIF-1α induced by influenza A (H1N1) infection is critical to the production of proinflammatory cytokinesThe PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.Pneumococcal Neuraminidase A (NanA) Promotes Biofilm Formation and Synergizes with Influenza A Virus in Nasal Colonization and Middle Ear Infection.The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.Sheng Jiang San, a traditional multi-herb formulation, exerts anti-influenza effects in vitro and in vivo via neuraminidase inhibition and immune regulation.Neuraminidase Inhibitors in Influenza Treatment and Prevention⁻Is It Time to Call It a Day?Treating Influenza Infection, From Now and Into the FutureAntiviral resistance markers in influenza virus sequences in Mexico, 2000-2017Mathematical Analysis of Influenza A Dynamics in the Emergence of Drug Resistance
P2860
Q28829917-D28D0CD6-0275-44ED-AECD-0A87E5DB55F1Q30375577-72F43BBF-CF33-42CE-9D35-928B8241145BQ30388331-5C195563-9CA1-4B33-BDA4-56DFC398547AQ30390117-A0AD1F73-82F4-40F0-B8C8-2BD011B8DEE3Q33795341-ABF36031-3094-41A0-8567-EA2CB8ED09C3Q34809686-DA702607-93F5-4F86-BE9F-0474B9C6F250Q35121118-A5C70DE1-A2C6-4E33-821D-C866C6F46C0AQ35321520-0655DC81-B7A1-4F4B-9083-0B1A66F16E5EQ35757609-DF5C04D4-1D20-439D-83D5-AA2E6A874EF0Q36249828-811DD574-9D5A-4EDB-8706-F6BDD9855CC6Q37737812-A71E6F19-CAA3-468F-B56D-4C73E087E448Q38618537-FAA514A8-4949-4927-9108-2BBE5DBA1384Q38696286-9B0620FF-71EB-442E-A087-7661ADDDD2B0Q38768252-F3342D13-41A9-4EA1-839E-346A6C0E8328Q38963385-632C96DF-A4F4-439C-B3B6-85E902624A1AQ39016249-916D67DA-3614-494E-849A-61AA33CCC4CFQ45323867-103D5778-5C3B-48EF-840D-94586871E518Q55000488-F8C681C5-16ED-4D2F-A8B7-6FDCC278F9A7Q57093850-1F2278A2-33F9-44DE-B0D4-6BA8892BB806Q57158941-8090A988-00DF-4195-ACFE-1D3EEEADB383Q57815887-D21F4936-F281-4816-B375-816FDDCD8875Q58693316-5B5A2DC8-B110-45A8-B715-0EE646D07869
P2860
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@ast
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@en
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@nl
type
label
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@ast
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@en
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@nl
prefLabel
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@ast
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@en
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@nl
P2860
P3181
P356
P1476
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
@en
P2093
Amanda Kamali
P2860
P304
P3181
P356
10.2147/IDR.S36601
P407
P577
2013-01-01T00:00:00Z